Patent · US Active

Sustained-release donepezil formulation

US9757338B2 · kind B2 · utility

0Cited by

24References

8Claims

0Family size

Assignee

DEXCEL PHARMA TECHNOLOGIES LTD. · IL

Inventors

Adel Penhasi · Holon, IL
Mila Gomberg · Jerusalem, IL

Key dates

Filing date	Feb 28, 2011
Grant date	Sep 12, 2017
Priority date	—
Expiry date	May 31, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A sustained-release formulation for an acetylcholinesterase inhibitor, comprising an acetylcholinesterase inhibitor and at least two gel-forming polymers, and methods of manufacture thereof. The acetylcholinesterase inhibitor preferably comprises donepezil.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.